NEW YORK(GenomeWeb) – Protein reagent firm Anatrace has completed its acquisition of Microlytic, which specializes in tools for the structural biology market.

In particular, Microlytic offers products intended to accelerate workflows and improve output quality in soluble protein crystallization.

Anatrace specializes in development and production of high-purity detergents and synthetic lipids for use in membrane protein work. The company is owned by StoneCalibre, a Century City, Calif.-based investment fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.